GLP-1 receptor modulators

GLP-1 receptor modulators

Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Huang, Liming, Knaggs, Michael, Meghani, Premji, Novak, Andrew, Fowler, Thomas, Martinborough, Esther, Yeager, Adam R, Glynn, Daniel, Tamiya, Junko, Moorjani, Manisha, Mills, Mark, Brahmachary, Enugurthi, Boehm, Marcus F
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Huang, Liming
Knaggs, Michael
Meghani, Premji
Novak, Andrew
Fowler, Thomas
Martinborough, Esther
Yeager, Adam R
Glynn, Daniel
Tamiya, Junko
Moorjani, Manisha
Mills, Mark
Brahmachary, Enugurthi
Boehm, Marcus F
description Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2015360364BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2015360364BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2015360364BB23</originalsourceid><addsrcrecordid>eNrjZJB09wnQNVQoSk1OLSjJL1LIzU8pzUkEsop5GFjTEnOKU3mhNDeDiptriLOHbmpBfnxqcUFicmpeakm8Y6iRgaGpsZmBsZmJk5ORMZHKALOeI4U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLP-1 receptor modulators</title><source>esp@cenet</source><creator>Huang, Liming ; Knaggs, Michael ; Meghani, Premji ; Novak, Andrew ; Fowler, Thomas ; Martinborough, Esther ; Yeager, Adam R ; Glynn, Daniel ; Tamiya, Junko ; Moorjani, Manisha ; Mills, Mark ; Brahmachary, Enugurthi ; Boehm, Marcus F</creator><creatorcontrib>Huang, Liming ; Knaggs, Michael ; Meghani, Premji ; Novak, Andrew ; Fowler, Thomas ; Martinborough, Esther ; Yeager, Adam R ; Glynn, Daniel ; Tamiya, Junko ; Moorjani, Manisha ; Mills, Mark ; Brahmachary, Enugurthi ; Boehm, Marcus F</creatorcontrib><description>Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200430&amp;DB=EPODOC&amp;CC=AU&amp;NR=2015360364B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200430&amp;DB=EPODOC&amp;CC=AU&amp;NR=2015360364B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Huang, Liming</creatorcontrib><creatorcontrib>Knaggs, Michael</creatorcontrib><creatorcontrib>Meghani, Premji</creatorcontrib><creatorcontrib>Novak, Andrew</creatorcontrib><creatorcontrib>Fowler, Thomas</creatorcontrib><creatorcontrib>Martinborough, Esther</creatorcontrib><creatorcontrib>Yeager, Adam R</creatorcontrib><creatorcontrib>Glynn, Daniel</creatorcontrib><creatorcontrib>Tamiya, Junko</creatorcontrib><creatorcontrib>Moorjani, Manisha</creatorcontrib><creatorcontrib>Mills, Mark</creatorcontrib><creatorcontrib>Brahmachary, Enugurthi</creatorcontrib><creatorcontrib>Boehm, Marcus F</creatorcontrib><title>GLP-1 receptor modulators</title><description>Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB09wnQNVQoSk1OLSjJL1LIzU8pzUkEsop5GFjTEnOKU3mhNDeDiptriLOHbmpBfnxqcUFicmpeakm8Y6iRgaGpsZmBsZmJk5ORMZHKALOeI4U</recordid><startdate>20200430</startdate><enddate>20200430</enddate><creator>Huang, Liming</creator><creator>Knaggs, Michael</creator><creator>Meghani, Premji</creator><creator>Novak, Andrew</creator><creator>Fowler, Thomas</creator><creator>Martinborough, Esther</creator><creator>Yeager, Adam R</creator><creator>Glynn, Daniel</creator><creator>Tamiya, Junko</creator><creator>Moorjani, Manisha</creator><creator>Mills, Mark</creator><creator>Brahmachary, Enugurthi</creator><creator>Boehm, Marcus F</creator><scope>EVB</scope></search><sort><creationdate>20200430</creationdate><title>GLP-1 receptor modulators</title><author>Huang, Liming ; Knaggs, Michael ; Meghani, Premji ; Novak, Andrew ; Fowler, Thomas ; Martinborough, Esther ; Yeager, Adam R ; Glynn, Daniel ; Tamiya, Junko ; Moorjani, Manisha ; Mills, Mark ; Brahmachary, Enugurthi ; Boehm, Marcus F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2015360364BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Huang, Liming</creatorcontrib><creatorcontrib>Knaggs, Michael</creatorcontrib><creatorcontrib>Meghani, Premji</creatorcontrib><creatorcontrib>Novak, Andrew</creatorcontrib><creatorcontrib>Fowler, Thomas</creatorcontrib><creatorcontrib>Martinborough, Esther</creatorcontrib><creatorcontrib>Yeager, Adam R</creatorcontrib><creatorcontrib>Glynn, Daniel</creatorcontrib><creatorcontrib>Tamiya, Junko</creatorcontrib><creatorcontrib>Moorjani, Manisha</creatorcontrib><creatorcontrib>Mills, Mark</creatorcontrib><creatorcontrib>Brahmachary, Enugurthi</creatorcontrib><creatorcontrib>Boehm, Marcus F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Huang, Liming</au><au>Knaggs, Michael</au><au>Meghani, Premji</au><au>Novak, Andrew</au><au>Fowler, Thomas</au><au>Martinborough, Esther</au><au>Yeager, Adam R</au><au>Glynn, Daniel</au><au>Tamiya, Junko</au><au>Moorjani, Manisha</au><au>Mills, Mark</au><au>Brahmachary, Enugurthi</au><au>Boehm, Marcus F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLP-1 receptor modulators</title><date>2020-04-30</date><risdate>2020</risdate><abstract>Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2015360364BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title GLP-1 receptor modulators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A43%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Huang,%20Liming&rft.date=2020-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2015360364BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true